• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    WNS Announces Addition of Tim Main to Board of Directors

    5/18/21 4:15:00 PM ET
    $WNS
    $DGX
    $JBL
    $SHAC
    Real Estate
    Real Estate
    Medical Specialities
    Health Care
    Get the next $WNS alert in real time by email

    WNS (Holdings) Limited (NYSE:WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the appointment of Timothy L. Main to the company's Board of Directors effective June 1, 2021. Tim has spent his entire career in a B2B services/outsourcing environment, including more than 25 years with Jabil, Inc. (NYSE:JBL), a leading provider of manufacturing services with a global operational footprint. At Jabil, Tim worked his way from a Production Control Manager position to eventually serve as President, Chief Executive Officer, and Chairman of the Board. During his 13-year tenure as Chief Executive Officer of Jabil, he led the company's transformation and growth to a $17+ billion, 100,000 employee organization through organic growth and strategic acquisitions. Tim is currently non-executive Chairman of the Board of Directors and a member of the Cyber Committee at Jabil. In addition, he serves on the Board of Quest Diagnostics (NYSE:DGX) as Chair of the Cybersecurity Committee and a member of the Audit & Finance and Governance committees, and on the Board of SCP & CO Healthcare Acquisition Co. (NASDAQ:SHAC), where he serves as a member of the Audit & Finance Committee.

    "Tim is a proven leader with a distinguished track record in international operations, corporate governance, vision and strategy, and technology-led growth," said Adrian T. Dillon, WNS's Chairman of the Board. "We are pleased to welcome Tim to the WNS Board of Directors, and believe that his experience guiding large organizations and developing talent will be a tremendous asset to the company."

    "The WNS team is delighted to add an experienced executive like Tim to our Board," said Keshav R. Murugesh, Chief Executive Officer of WNS. "His background in leading high-performing teams, driving both organic and inorganic revenue growth, and managing global operations will help WNS continue to generate exceptional value for all of our key stakeholders."

    About WNS

    WNS (Holdings) Limited (NYSE:WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 375 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer interaction services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of March 31, 2021, WNS had 43,997 professionals across 58 delivery centers worldwide including facilities in Australia, China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, the United Kingdom, and the United States. For more information, visit www.wns.com.

    Safe Harbor Provision

    This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the Securities and Exchange Commission. WNS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006071/en/

    Get the next $WNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WNS
    $DGX
    $JBL
    $SHAC

    CompanyDatePrice TargetRatingAnalyst
    Jabil Inc.
    $JBL
    3/12/2026$275.00Outperform
    Robert W. Baird
    Quest Diagnostics Incorporated
    $DGX
    1/30/2026$210.00Equal Weight → Overweight
    Barclays
    Quest Diagnostics Incorporated
    $DGX
    8/25/2025$194.00Outperform → Neutral
    Robert W. Baird
    WNS (Holdings) Limited
    $WNS
    7/17/2025Hold
    Deutsche Bank
    Jabil Inc.
    $JBL
    7/2/2025$245.00Buy
    Stifel
    Jabil Inc.
    $JBL
    6/18/2025Hold → Buy
    Argus
    Quest Diagnostics Incorporated
    $DGX
    4/2/2025$195.00Buy
    Redburn Atlantic
    Quest Diagnostics Incorporated
    $DGX
    3/4/2025$185.00Buy → Neutral
    Citigroup
    More analyst ratings

    $WNS
    $DGX
    $JBL
    $SHAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Badger Technologies Names Retail Industry Veteran John Gehre CEO, Expands Leadership Team

    New executive leadership team and Strategic Advisory Board position the company for its next phase of growth as retailers increasingly seek AI-powered solutions to improve operational performance, inventory visibility and store execution. Badger Technologies, a product division of Jabil Inc. (NYSE:JBL), today announced the appointment of retail industry veteran John Gehre as Chief Executive Officer, alongside expanded leadership roles for Chris Green and Paul Ambruso, and the formation of the company's inaugural Strategic Advisory Board. The appointments mark a milestone in the company's development, as retailers increasingly seek AI-powered retail intelligence solutions to improve inve

    6/25/26 8:30:00 AM ET
    $JBL
    Electrical Products
    Technology

    Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing

    Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack MRD for patients with solid tumor cancersSECAUCUS, N.J., June 24, 2026 /PRNewswire/ -- Quest Diagnostics® (NYSE:DGX), a leading provider of diagnostic information services, today announced that the New York State Department of Health's (NYSDOH) Clinical Laboratory Evaluation Program (CLEP) has approved the company's Haystack MRD® test, a circulating tumor DNA (ctDNA) liquid biopsy test, for use in identifying residual or recurring disease in patients with a range of solid tumor cancers.

    6/24/26 8:52:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics

    Published in Nature Communications, the new study finds that nearly 70% of a common bacterial strain that causes urinary tract infections, pneumonia and wound infections was non-susceptible to the three most used oral antibioticsSECAUCUS, N.J., June 18, 2026 /PRNewswire/ -- A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especially when it becomes multidrug-resistant and causes chronic urinary-tract infections (UTIs) in elderly women. But the extent of its effect on the broader population and its prevalence in the community was not well known – until now. Klebs

    6/18/26 8:57:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    $WNS
    $DGX
    $JBL
    $SHAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Robert W. Baird initiated coverage on Jabil with a new price target

    Robert W. Baird initiated coverage of Jabil with a rating of Outperform and set a new price target of $275.00

    3/12/26 8:53:39 AM ET
    $JBL
    Electrical Products
    Technology

    Quest Diagnostics upgraded by Barclays with a new price target

    Barclays upgraded Quest Diagnostics from Equal Weight to Overweight and set a new price target of $210.00

    1/30/26 6:40:39 AM ET
    $DGX
    Medical Specialities
    Health Care

    Quest Diagnostics downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Quest Diagnostics from Outperform to Neutral and set a new price target of $194.00

    8/25/25 8:10:20 AM ET
    $DGX
    Medical Specialities
    Health Care

    $WNS
    $DGX
    $JBL
    $SHAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Clinical Solutions Kuppusamy Karthik exercised 8,147 shares at a strike of $124.22 and sold $1,629,400 worth of shares (8,147 units at $200.00) as part of a pre-agreed trading plan (SEC Form 4)

    4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)

    6/8/26 4:32:30 PM ET
    $DGX
    Medical Specialities
    Health Care

    CEO and President Davis J. E. sold $1,941,400 worth of shares (10,000 units at $194.14) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 132,423 units (SEC Form 4)

    4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)

    6/2/26 6:38:38 PM ET
    $DGX
    Medical Specialities
    Health Care

    Director Carter Robert B was granted 1,142 shares, increasing direct ownership by 42% to 3,853 units (SEC Form 4)

    4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)

    5/21/26 4:59:34 PM ET
    $DGX
    Medical Specialities
    Health Care

    $WNS
    $DGX
    $JBL
    $SHAC
    SEC Filings

    View All

    SEC Form 11-K filed by Quest Diagnostics Incorporated

    11-K - QUEST DIAGNOSTICS INC (0001022079) (Filer)

    6/18/26 4:12:03 PM ET
    $DGX
    Medical Specialities
    Health Care

    Jabil Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - JABIL INC (0000898293) (Filer)

    6/17/26 7:32:41 AM ET
    $JBL
    Electrical Products
    Technology

    SEC Form SD filed by Jabil Inc.

    SD - JABIL INC (0000898293) (Filer)

    5/26/26 5:07:43 PM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP Chintapalli Anil bought $1,115,226 worth of shares (20,000 units at $55.76), increasing direct ownership by 72% to 47,900 units (SEC Form 4)

    4 - WNS (HOLDINGS) LTD (0001356570) (Issuer)

    6/2/25 4:41:04 PM ET
    $WNS
    Real Estate

    $WNS
    $DGX
    $JBL
    $SHAC
    Leadership Updates

    Live Leadership Updates

    View All

    Badger Technologies Names Retail Industry Veteran John Gehre CEO, Expands Leadership Team

    New executive leadership team and Strategic Advisory Board position the company for its next phase of growth as retailers increasingly seek AI-powered solutions to improve operational performance, inventory visibility and store execution. Badger Technologies, a product division of Jabil Inc. (NYSE:JBL), today announced the appointment of retail industry veteran John Gehre as Chief Executive Officer, alongside expanded leadership roles for Chris Green and Paul Ambruso, and the formation of the company's inaugural Strategic Advisory Board. The appointments mark a milestone in the company's development, as retailers increasingly seek AI-powered retail intelligence solutions to improve inve

    6/25/26 8:30:00 AM ET
    $JBL
    Electrical Products
    Technology

    Dycom Industries, Inc. Appoints Raejeanne Skillern to Board of Directors

    WEST PALM BEACH, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE:DY) today announced the appointment of Raejeanne Skillern to its Board of Directors, effective March 24, 2026. Ms. Skillern is a highly regarded technology executive with over 30 years of leadership experience spanning hyperscale cloud, data center infrastructure, communications and artificial intelligence. She has a proven track record of leading multi-billion-dollar business units at global organizations including Amazon Web Services (AWS), Intel and Flex. "We are pleased to welcome Raejeanne to the Dycom Board of Directors," said Richard K. Sykes, Dycom's Independent Chairman of the Board. "Her de

    3/24/26 4:30:00 PM ET
    $DY
    $JBL
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials
    Electrical Products
    Technology

    Jabil Announces Appointment of New Chairman, Directors to the Board

    Jabil Inc. (NYSE:JBL), a global engineering, supply chain, and manufacturing solutions provider, today announced that Steve Raymund has been appointed Chairman of its Board of Directors. Additionally, Thomas T. Edman and Raejeanne Skillern have been appointed to its Board of Directors. "I am honored to accept this role and look forward to collaborating with the rest of the Board to continue advancing Jabil's strategic direction," said Raymund. "We are also pleased to welcome Tom and Raejeanne to our Board. Tom's leadership in electronics manufacturing paired with Raejeanne's experience in key growth industries like cloud and data centers will be terrific additions to Jabil." Mr. Raymund

    1/22/26 4:15:00 PM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Jabil Inc.

    SC 13G/A - JABIL INC (0000898293) (Subject)

    11/12/24 10:32:13 AM ET
    $JBL
    Electrical Products
    Technology

    Amendment: SEC Form SC 13G/A filed by WNS (Holdings) Limited

    SC 13G/A - WNS (HOLDINGS) LTD (0001356570) (Subject)

    11/1/24 4:27:50 PM ET
    $WNS
    Real Estate

    Amendment: SEC Form SC 13G/A filed by WNS (Holdings) Limited

    SC 13G/A - WNS (HOLDINGS) LTD (0001356570) (Subject)

    7/10/24 10:10:34 AM ET
    $WNS
    Real Estate

    $WNS
    $DGX
    $JBL
    $SHAC
    Financials

    Live finance-specific insights

    View All

    Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026

    SECAUCUS, N.J., June 17, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leader in diagnostic information services, announced today that it will report its second quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company

    6/17/26 9:00:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    Jabil Posts Third Quarter Results

    Raises Fiscal 2026 Outlook Today, Jabil Inc. (NYSE:JBL), reported preliminary, unaudited financial results for its third quarter of fiscal year 2026. Third Quarter of Fiscal Year 2026 Highlights: Net revenue: $8.8 billion U.S. GAAP operating income: $445 million U.S. GAAP diluted earnings per share: $2.59 Core operating income (Non-GAAP): $504 million Core diluted earnings per share (Non-GAAP): $3.16 "Jabil delivered a very strong third quarter, with results ahead of our expectations across revenue, core operating margin, core EPS, and free cash flow," said CEO Mike Dastoor. "AI infrastructure demand remains extremely strong, and our full-year AI-related revenue outloo

    6/17/26 7:30:00 AM ET
    $JBL
    Electrical Products
    Technology

    Jabil's Third Quarter of Fiscal Year 2026 Earnings Announcement Set

    Jabil Inc. (NYSE:JBL) today announced it will release its third quarter of fiscal year 2026 financials on Wednesday, June 17, 2026, before the market opens. The company will host a conference call and webcast to review the results. What: Jabil's Third Quarter of Fiscal Year 2026 Conference Call and Webcast When: Wednesday, June 17, 2026 – 8:30 a.m. ET Dial-in: U.S. (877) 407-6184 or International (201) 389-0877 To access the live audio webcast and the accompanying slide presentation, visit the Investor Relations section of Jabil's website, located at https://investors.jabil.com. An archived replay of the webcast will be available after completion of the call. About Jabil: At Jab

    6/3/26 8:30:00 AM ET
    $JBL
    Electrical Products
    Technology